Cure & Advancements/March 12, 2026/2 min read

Global Type 1 Diabetes Screening Efforts Expand Across Multiple Continents

Researchers gathered at ATTD 2026 in Barcelona highlighted major growth in T1D screening initiatives worldwide. Early detection of the condition is becoming a central focus for the research community.

News report — unverified, pending corroboration

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cure researchbeta cellsadvancements

Key takeaways

Type 1 diabetes screening numbers are growing significantly across the U.S., Europe, Australia, Qatar, Israel, and Central America
Early screening and detection has become a key priority for major T1D research organizations
The landscape of T1D screening has advanced substantially in recent years
International initiatives like EDENT1FI are working to expand screening for both children and adults globally

A Global Conference on T1D Progress

In March 2026, leading type 1 diabetes researchers, healthcare professionals, and industry partners gathered in Barcelona, Spain for the Advanced Technologies & Treatments for Diabetes (ATTD) conference. The event brought together experts to share recent scientific advances in T1D research and treatment, with significant participation from Breakthrough T1D—a major organization supporting T1D research and innovation.

Screening and Early Detection Take Center Stage

One of the most prominent topics at the conference was the importance of screening people for early signs of type 1 diabetes. Multiple presentations emphasized why expanding screening efforts matters for the goal of a world without T1D.

Early detection allows for earlier intervention and monitoring, which is why researchers are focused on identifying more people at risk—including both children and adults—before symptoms develop.

Screening Expansion Across the World

The number of people being screened for type 1 diabetes is growing significantly around the globe. This expansion is happening not just in the United States, but across Europe, Australia, Qatar, Israel, and now in Central America.

An international screening initiative called EDENT1FI, supported by Breakthrough T1D, presented data on screening efforts from around the world. This coordinated approach reflects how researchers are working across borders to identify people at risk of developing T1D earlier than would otherwise be possible.

A Rapidly Evolving Field

The current landscape of T1D screening has changed dramatically in recent years. As technology improves and awareness grows, screening programs are becoming more accessible and effective at identifying at-risk individuals before diabetes develops.

Evidence label

Origin: breakthrought1d.org (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.